FAS and adenocarcinoma: According to previous reports, FAS expression was progressively decreased during tumour progression from normal epithelium to adenocarcinoma (Leithauser et al, 1993; Moller et al, 1994), which leads to conclude that other factors rather than receptor expression alone influence cell sensitisation.